Details of the Drug Combinations

General Information of This Drug (ID: DMU8L7C)

Drug Name

Mepacrine DMU8L7C

Synonyms

quinacrine; mepacrine; atabrine; Acrinamine; Acriquine; 83-89-6; Quinactine; Antimalarina; Haffkinine; Akrichin; Italchine; acrichine; Erion; Mepacrinum; Quinacrine hydrochloride; Mepacrine [INN:BAN]; St 439; Mepacrinum [INN-Latin]; Mepacrina [INN-Spanish]; atebrin; Malaricida; Methoquine; Palacrin; Italchin; Pentilen; Palusan; Atebrine; Metochin; Mecryl; Quinacrine, Mepacrine; 3-Chloro-7-methoxy-9-(1-methyl-4-diethylaminobutylamino)acridine; 2-Methoxy-6-chloro-9-diethylaminopentylaminoacridine; HSDB 3253

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

271 Investigative Drug Combination(s) Consisting of This drug

Normalized Drug Combination Synergy Score

Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
10-hydroxycamptothecin + Mepacrine	DC9JZVC	10-hydroxycamptothecin	Glioma (Cell Line: SF-539)	[2]
10-hydroxycamptothecin + Mepacrine	DCY3FAI	10-hydroxycamptothecin	Adenocarcinoma (Cell Line: DU-145)	[3]
ABIRATERONE + Mepacrine	DCA8IQM	ABIRATERONE	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
ABIRATERONE + Mepacrine	DCFRQJ9	ABIRATERONE	Renal cell carcinoma (Cell Line: UO-31)	[2]
Amonafide + Mepacrine	DCEXWGY	Amonafide	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
Amonafide + Mepacrine	DCFVE67	Amonafide	Renal cell carcinoma (Cell Line: UO-31)	[2]
Anastrozole + Mepacrine	DC9RABQ	Anastrozole	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Anastrozole + Mepacrine	DC1A6JX	Anastrozole	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
Anastrozole + Mepacrine	DCPGUWF	Anastrozole	Lung adenocarcinoma (Cell Line: NCI-H522)	[2]
Anastrozole + Mepacrine	DC9VIY0	Anastrozole	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[2]
Anastrozole + Mepacrine	DCNUJMX	Anastrozole	Papillary renal cell carcinoma (Cell Line: ACHN)	[2]
Anastrozole + Mepacrine	DC9LK0W	Anastrozole	Prostate carcinoma (Cell Line: PC-3)	[2]
Anastrozole + Mepacrine	DCWLIE6	Anastrozole	Renal cell carcinoma (Cell Line: UO-31)	[2]
Arfolitixorin + Mepacrine	DC8RCNR	Arfolitixorin	Colon carcinoma (Cell Line: KM12)	[4]
Arfolitixorin + Mepacrine	DCRQUQN	Arfolitixorin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Azacitidine + Mepacrine	DCO44DS	Azacitidine	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Azacitidine + Mepacrine	DCH32D4	Azacitidine	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Azacitidine + Mepacrine	DCCERSI	Azacitidine	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[2]
Azacitidine + Mepacrine	DC1UWNX	Azacitidine	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[2]
Azacitidine + Mepacrine	DCLLHIS	Azacitidine	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
BIO-300 + Mepacrine	DC3UUUO	BIO-300	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
BIO-300 + Mepacrine	DC5NOK7	BIO-300	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
BIO-300 + Mepacrine	DCWPD51	BIO-300	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Bleomycin + Mepacrine	DCL8KTM	Bleomycin	Papillary renal cell carcinoma (Cell Line: ACHN)	[2]
Bleomycin + Mepacrine	DCV7GP8	Bleomycin	Adenocarcinoma (Cell Line: HT29)	[3]
Bleomycin + Mepacrine	DCPP8LW	Bleomycin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Cabazitaxel + Mepacrine	DCQ7M2B	Cabazitaxel	Amelanotic melanoma (Cell Line: M14)	[2]
Cabazitaxel + Mepacrine	DCDJ0HN	Cabazitaxel	Astrocytoma (Cell Line: SNB-19)	[2]
Cabazitaxel + Mepacrine	DC10HZE	Cabazitaxel	Clear cell renal cell carcinoma (Cell Line: 786-0)	[2]
Cabazitaxel + Mepacrine	DCIPX8T	Cabazitaxel	Clear cell renal cell carcinoma (Cell Line: TK-10)	[2]
Cabazitaxel + Mepacrine	DCH4KJG	Cabazitaxel	Glioma (Cell Line: SF-539)	[2]
Cabazitaxel + Mepacrine	DC48R0D	Cabazitaxel	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[2]
Cabazitaxel + Mepacrine	DCURPV7	Cabazitaxel	Renal cell carcinoma (Cell Line: UO-31)	[2]
Cabazitaxel + Mepacrine	DC4J9WV	Cabazitaxel	Carcinoma (Cell Line: MCF7)	[4]
Cabazitaxel + Mepacrine	DCU2SXP	Cabazitaxel	Invasive ductal carcinoma (Cell Line: HS 578T)	[4]
Dacarbazine + Mepacrine	DCSH27S	Dacarbazine	Lung adenocarcinoma (Cell Line: NCI-H522)	[2]
Dacarbazine + Mepacrine	DC3ARZ4	Dacarbazine	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[2]
Dacarbazine + Mepacrine	DCTJKER	Dacarbazine	Colon carcinoma (Cell Line: KM12)	[4]
Dactinomycin + Mepacrine	DC2GRFO	Dactinomycin	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Dactinomycin + Mepacrine	DC8T6OR	Dactinomycin	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Dactinomycin + Mepacrine	DCPTM2E	Dactinomycin	Plasma cell myeloma (Cell Line: RPMI-8226)	[3]
Dasatinib + Mepacrine	DCUM5RK	Dasatinib	Adenocarcinoma (Cell Line: HCT-15)	[2]
Dasatinib + Mepacrine	DCT72W5	Dasatinib	Amelanotic melanoma (Cell Line: MDA-MB-435)	[2]
Dasatinib + Mepacrine	DC6UPN5	Dasatinib	Amelanotic melanoma (Cell Line: M14)	[2]
Dasatinib + Mepacrine	DCIFZ70	Dasatinib	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Dasatinib + Mepacrine	DCUENM9	Dasatinib	Astrocytoma (Cell Line: U251)	[2]
Dasatinib + Mepacrine	DCD4O2E	Dasatinib	Cutaneous melanoma (Cell Line: SK-MEL-5)	[2]
Dasatinib + Mepacrine	DCPKIPN	Dasatinib	Colon carcinoma (Cell Line: KM12)	[4]
Dexrazoxane + Mepacrine	DCPHWFA	Dexrazoxane	Papillary renal cell carcinoma (Cell Line: ACHN)	[2]
Dexrazoxane + Mepacrine	DCN3RCX	Dexrazoxane	Colon carcinoma (Cell Line: KM12)	[4]
DFN-15 + Mepacrine	DC6NPUR	DFN-15	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
DFN-15 + Mepacrine	DCMYGI1	DFN-15	Astrocytoma (Cell Line: U251)	[2]
DFN-15 + Mepacrine	DCGBUB9	DFN-15	Glioblastoma (Cell Line: SNB-75)	[2]
DFN-15 + Mepacrine	DC6PX5G	DFN-15	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
DFN-15 + Mepacrine	DCNHXUS	DFN-15	Carcinoma (Cell Line: MCF7)	[4]
DFN-15 + Mepacrine	DCIJRLK	DFN-15	Colon carcinoma (Cell Line: KM12)	[4]
DFN-15 + Mepacrine	DC9RMJR	DFN-15	Adenocarcinoma (Cell Line: DU-145)	[3]
DFN-15 + Mepacrine	DC5M7I7	DFN-15	Adenocarcinoma (Cell Line: HCT116)	[3]
DFN-15 + Mepacrine	DC2UYYO	DFN-15	Adenocarcinoma (Cell Line: HT29)	[3]
DFN-15 + Mepacrine	DCZ8H2X	DFN-15	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
DFN-15 + Mepacrine	DCE8EK1	DFN-15	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
DFN-15 + Mepacrine	DC4C9X9	DFN-15	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
DFN-15 + Mepacrine	DC25HUA	DFN-15	Lung adenocarcinoma (Cell Line: HOP-62)	[3]
DFN-15 + Mepacrine	DCI2KKX	DFN-15	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
DFN-15 + Mepacrine	DC9EKV1	DFN-15	Malignant melanoma (Cell Line: UACC62)	[3]
Docetaxel + Mepacrine	DCV2O7G	Docetaxel	Adenocarcinoma (Cell Line: HCT116)	[2]
Epirubicin + Mepacrine	DCAOSPF	Epirubicin	Renal cell carcinoma (Cell Line: UO-31)	[2]
Estramustine + Mepacrine	DCCMPTG	Estramustine	Colon carcinoma (Cell Line: KM12)	[4]
Estramustine + Mepacrine	DCPGLMJ	Estramustine	Adenocarcinoma (Cell Line: OVCAR3)	[3]
Estramustine + Mepacrine	DCO7QWE	Estramustine	Adenocarcinoma (Cell Line: SW-620)	[3]
Estramustine + Mepacrine	DCQPNAT	Estramustine	Adenocarcinoma (Cell Line: HCT116)	[3]
Estramustine + Mepacrine	DCDJN9W	Estramustine	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Estramustine + Mepacrine	DCZWKDR	Estramustine	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Estramustine + Mepacrine	DCR889E	Estramustine	Melanoma (Cell Line: SK-MEL-2)	[3]
FORMESTANE + Mepacrine	DC3G3Z0	FORMESTANE	Adenocarcinoma (Cell Line: DU-145)	[2]
FORMESTANE + Mepacrine	DCPY9AJ	FORMESTANE	Adenocarcinoma (Cell Line: SW-620)	[2]
FORMESTANE + Mepacrine	DCKAEF2	FORMESTANE	Adenocarcinoma (Cell Line: HT29)	[2]
FORMESTANE + Mepacrine	DCW4N4V	FORMESTANE	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
FORMESTANE + Mepacrine	DCYU0R5	FORMESTANE	Amelanotic melanoma (Cell Line: M14)	[2]
FORMESTANE + Mepacrine	DCYP8MC	FORMESTANE	Amelanotic melanoma (Cell Line: MDA-MB-435)	[2]
FORMESTANE + Mepacrine	DC894JO	FORMESTANE	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
FORMESTANE + Mepacrine	DCQR1US	FORMESTANE	Astrocytoma (Cell Line: U251)	[2]
FORMESTANE + Mepacrine	DCTQ56Z	FORMESTANE	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
FORMESTANE + Mepacrine	DCWJX2R	FORMESTANE	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
FORMESTANE + Mepacrine	DCH6WPO	FORMESTANE	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
FORMESTANE + Mepacrine	DCWS2NO	FORMESTANE	Lung adenocarcinoma (Cell Line: HOP-62)	[2]
FORMESTANE + Mepacrine	DC1P6IH	FORMESTANE	Malignant melanoma (Cell Line: UACC62)	[2]
FORMESTANE + Mepacrine	DC8ZT0F	FORMESTANE	Melanoma (Cell Line: SK-MEL-2)	[2]
FORMESTANE + Mepacrine	DC0O5GW	FORMESTANE	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
FORMESTANE + Mepacrine	DCPW03Q	FORMESTANE	Prostate carcinoma (Cell Line: PC-3)	[2]
FORMESTANE + Mepacrine	DC58O09	FORMESTANE	Colon carcinoma (Cell Line: KM12)	[4]
Fulvestrant + Mepacrine	DC1J6C4	Fulvestrant	Adenocarcinoma (Cell Line: OVCAR3)	[2]
Fulvestrant + Mepacrine	DCV633L	Fulvestrant	Adenocarcinoma (Cell Line: HCT-15)	[2]
Fulvestrant + Mepacrine	DCBMXGC	Fulvestrant	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Gefitinib + Mepacrine	DCOFUUH	Gefitinib	Adenocarcinoma (Cell Line: SW-620)	[2]
Gefitinib + Mepacrine	DC6MWLG	Gefitinib	Lung adenocarcinoma (Cell Line: NCI-H522)	[2]
Gefitinib + Mepacrine	DCPOR6R	Gefitinib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[2]
Gefitinib + Mepacrine	DCCDHY2	Gefitinib	Papillary renal cell carcinoma (Cell Line: ACHN)	[2]
Gefitinib + Mepacrine	DCPIVTI	Gefitinib	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[2]
Gefitinib + Mepacrine	DCSVF0O	Gefitinib	Colon carcinoma (Cell Line: KM12)	[4]
Hepzato + Mepacrine	DC445JV	Hepzato	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Hepzato + Mepacrine	DC14D95	Hepzato	Astrocytoma (Cell Line: U251)	[2]
Hepzato + Mepacrine	DCKWHM0	Hepzato	Colon carcinoma (Cell Line: KM12)	[4]
Hepzato + Mepacrine	DC6V8PH	Hepzato	Adenocarcinoma (Cell Line: SW-620)	[3]
Hepzato + Mepacrine	DC101IB	Hepzato	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Hepzato + Mepacrine	DC5MRHC	Hepzato	Cutaneous melanoma (Cell Line: SK-MEL-5)	[3]
Hepzato + Mepacrine	DCTZDQ6	Hepzato	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Hepzato + Mepacrine	DCQXOD7	Hepzato	Melanoma (Cell Line: SK-MEL-2)	[3]
Hepzato + Mepacrine	DCVRI70	Hepzato	Prostate carcinoma (Cell Line: PC-3)	[3]
Imatinib + Mepacrine	DCJC5DA	Imatinib	Glioma (Cell Line: SF-295)	[2]
Imatinib + Mepacrine	DCDBY4F	Imatinib	Melanoma (Cell Line: SK-MEL-2)	[2]
Imatinib + Mepacrine	DC3C6Y5	Imatinib	Carcinoma (Cell Line: MCF7)	[4]
Indazole derivative 5 + Mepacrine	DCV7VGO	Indazole derivative 5	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Indazole derivative 5 + Mepacrine	DCJXFOH	Indazole derivative 5	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
JNK-IN-8 + Mepacrine	DC67NXJ	JNK-IN-8	Renal cell carcinoma (Cell Line: UO-31)	[2]
JNK-IN-8 + Mepacrine	DCOMS2B	JNK-IN-8	Lung adenocarcinoma (Cell Line: EKVX)	[3]
JNK-IN-8 + Mepacrine	DCJS465	JNK-IN-8	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Lapatinib + Mepacrine	DCJMECB	Lapatinib	Adenocarcinoma (Cell Line: OVCAR3)	[3]
Lenalidomide + Mepacrine	DC7F9HT	Lenalidomide	Renal cell carcinoma (Cell Line: UO-31)	[2]
Lenalidomide + Mepacrine	DCC15YH	Lenalidomide	Colon carcinoma (Cell Line: KM12)	[4]
Lenalidomide + Mepacrine	DCXGNKR	Lenalidomide	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Lenalidomide + Mepacrine	DCPDJFR	Lenalidomide	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Letrozole + Mepacrine	DC5AWF5	Letrozole	Carcinoma (Cell Line: MCF7)	[4]
LIAROZOLE + Mepacrine	DCYXN6J	LIAROZOLE	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Mechlorethamine + Mepacrine	DC2GWLW	Mechlorethamine	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Mechlorethamine + Mepacrine	DCKHI74	Mechlorethamine	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Mechlorethamine + Mepacrine	DCLRTUV	Mechlorethamine	Colon carcinoma (Cell Line: KM12)	[4]
Mechlorethamine + Mepacrine	DCNSWNO	Mechlorethamine	Adenocarcinoma (Cell Line: HCT116)	[3]
Mechlorethamine + Mepacrine	DCH8RJD	Mechlorethamine	Adenocarcinoma (Cell Line: SW-620)	[3]
Mechlorethamine + Mepacrine	DC34G8K	Mechlorethamine	Malignant melanoma (Cell Line: UACC62)	[3]
Mepacrine + Pentostatin	DCF894Y	Pentostatin	Astrocytoma (Cell Line: U251)	[2]
Mepacrine + Pentostatin	DC0JL64	Pentostatin	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Mepacrine + Pentostatin	DCJCZP5	Pentostatin	Clear cell renal cell carcinoma (Cell Line: TK-10)	[2]
Mepacrine + Isoniazid	DCBK492	Isoniazid	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Mepacrine + Isoniazid	DCE6J7R	Isoniazid	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Mepacrine + Isoniazid	DCOE8K7	Isoniazid	Glioma (Cell Line: SF-268)	[2]
Mepacrine + Ifosfamide	DCWXFJP	Ifosfamide	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Mepacrine + Altretamine	DCX8OZ4	Altretamine	Papillary renal cell carcinoma (Cell Line: ACHN)	[2]
Mepacrine + TEM	DCUAMTD	TEM	Clear cell renal cell carcinoma (Cell Line: TK-10)	[2]
Mepacrine + TEM	DCO0PR8	TEM	Glioma (Cell Line: SF-539)	[2]
Mepacrine + Idarubicin	DCT6TXN	Idarubicin	Glioblastoma? (Cell Line: T98G)	[2]
Mepacrine + Bortezomib	DC9SGZP	Bortezomib	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Mepacrine + Cisplatin	DCN1SHY	Cisplatin	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Mepacrine + Cisplatin	DCVHQXY	Cisplatin	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
Mepacrine + Chlorambucil	DCERFW1	Chlorambucil	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Mepacrine + Chlorambucil	DC3XCMO	Chlorambucil	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Mepacrine + Chlorambucil	DCF5EPM	Chlorambucil	Glioma (Cell Line: SF-295)	[2]
Mepacrine + Chlorambucil	DC04QL2	Chlorambucil	Plasma cell myeloma (Cell Line: RPMI-8226)	[2]
Mepacrine + ER819762	DC3YOSP	ER819762	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Mepacrine + Pomalidomide	DCIJNOZ	Pomalidomide	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Mepacrine + PMID28870136-Compound-43	DC9TNNG	PMID28870136-Compound-43	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Mepacrine + PMID28870136-Compound-43	DCZ3M8A	PMID28870136-Compound-43	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Mepacrine + PMID28870136-Compound-43	DCBNR74	PMID28870136-Compound-43	Astrocytoma (Cell Line: U251)	[2]
Mepacrine + PMID28870136-Compound-43	DCLNV5M	PMID28870136-Compound-43	Glioma (Cell Line: SF-539)	[2]
Mepacrine + Busulfan	DCRXWJX	Busulfan	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Mepacrine + Pentostatin	DCIPFI6	Pentostatin	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Mepacrine + Arsenic trioxide	DCI8Q89	Arsenic trioxide	Colon adenocarcinoma (Cell Line: COLO 205)	[4]
Mepacrine + TEM	DCT5O0V	TEM	Carcinoma (Cell Line: RXF 393)	[4]
Mepacrine + TEM	DCUTIEY	TEM	Colon carcinoma (Cell Line: KM12)	[4]
Mepacrine + PMID28870136-Compound-43	DC92J59	PMID28870136-Compound-43	Colon carcinoma (Cell Line: KM12)	[4]
Mepacrine + Busulfan	DCNP7TG	Busulfan	Colon carcinoma (Cell Line: KM12)	[4]
Mepacrine + Busulfan	DC1702T	Busulfan	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Mepacrine + Pentostatin	DCFHGBT	Pentostatin	Adenocarcinoma (Cell Line: HCT-15)	[3]
Mepacrine + Pentostatin	DC1F2Z7	Pentostatin	Melanoma (Cell Line: UACC-257)	[3]
Mepacrine + Cyclophosphamide	DC9DAM1	Cyclophosphamide	Adenocarcinoma (Cell Line: HCT-15)	[3]
Mepacrine + Cyclophosphamide	DCZPOX3	Cyclophosphamide	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Mepacrine + Cyclophosphamide	DCA3US8	Cyclophosphamide	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Mepacrine + Isoniazid	DCKD3OX	Isoniazid	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Mepacrine + Isoniazid	DCOMFUV	Isoniazid	Malignant melanoma (Cell Line: UACC62)	[3]
Mepacrine + Isoniazid	DCIJNXN	Isoniazid	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Mepacrine + Arsenic trioxide	DCFL289	Arsenic trioxide	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-5)	[3]
Mepacrine + Arsenic trioxide	DC3LN1H	Arsenic trioxide	Lung adenocarcinoma (Cell Line: EKVX)	[3]
Mepacrine + Arsenic trioxide	DCPP4SP	Arsenic trioxide	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Mepacrine + Arsenic trioxide	DC0TUXN	Arsenic trioxide	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Mepacrine + Topetecan	DCW22PY	Topetecan	Adenocarcinoma (Cell Line: HCC-2998)	[3]
Mepacrine + Mitomycin	DCJO08Q	Mitomycin	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Mepacrine + Mitomycin	DCJVUDA	Mitomycin	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Mepacrine + Mitomycin	DCRUE9E	Mitomycin	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Mepacrine + Altretamine	DCS3ZM9	Altretamine	Adenocarcinoma (Cell Line: NCIH23)	[3]
Mepacrine + Altretamine	DC0KVFQ	Altretamine	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Mepacrine + Altretamine	DCMGPY8	Altretamine	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Mepacrine + TEM	DCEIPFN	TEM	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Mepacrine + TEM	DCK2COL	TEM	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Mepacrine + Cisplatin	DC0IASI	Cisplatin	Adenocarcinoma (Cell Line: DU-145)	[3]
Mepacrine + Cisplatin	DCKPKSB	Cisplatin	Melanoma (Cell Line: UACC-257)	[3]
Mepacrine + Chlorambucil	DCDKAYR	Chlorambucil	Adenocarcinoma (Cell Line: HT29)	[3]
Mepacrine + Chlorambucil	DCTWEJ5	Chlorambucil	Lung adenocarcinoma (Cell Line: MDA-MB-231)	[3]
Mepacrine + Chlorambucil	DCY5LOQ	Chlorambucil	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Mepacrine + ER819762	DC9Q3VR	ER819762	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Mepacrine + ER819762	DCFY83U	ER819762	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Mepacrine + Pomalidomide	DC8OWIZ	Pomalidomide	Adenocarcinoma (Cell Line: OVCAR3)	[3]
Mepacrine + Pomalidomide	DCBKVF8	Pomalidomide	Melanoma (Cell Line: UACC-257)	[3]
Mepacrine + PMID28870136-Compound-43	DC5Q0IT	PMID28870136-Compound-43	Adenocarcinoma (Cell Line: SW-620)	[3]
Mepacrine + PMID28870136-Compound-43	DCUA91C	PMID28870136-Compound-43	Adenocarcinoma (Cell Line: HCT116)	[3]
Mepacrine + Aminolevulinic Acid Hydrochloride	DC047G2	Aminolevulinic Acid Hydrochloride	Adenocarcinoma (Cell Line: DU-145)	[3]
Mepacrine + Aminolevulinic Acid Hydrochloride	DCRZ59J	Aminolevulinic Acid Hydrochloride	Melanoma (Cell Line: MALME-3M)	[3]
Mepacrine + Busulfan	DCS6ZHR	Busulfan	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Methotrexate + Mepacrine	DCS13Z0	Methotrexate	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Methotrexate + Mepacrine	DCBV5GL	Methotrexate	Amelanotic melanoma (Cell Line: M14)	[2]
Methotrexate + Mepacrine	DCV7XXJ	Methotrexate	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Methotrexate + Mepacrine	DC2E97P	Methotrexate	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Nilotinib + Mepacrine	DC956KY	Nilotinib	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Picoplatin + Mepacrine	DC3NCVL	Picoplatin	Renal cell carcinoma (Cell Line: UO-31)	[2]
Picoplatin + Mepacrine	DCMKCNU	Picoplatin	Colon carcinoma (Cell Line: KM12)	[4]
Picoplatin + Mepacrine	DCRBW3J	Picoplatin	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Picoplatin + Mepacrine	DCXZ7JE	Picoplatin	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Picoplatin + Mepacrine	DC6V5TV	Picoplatin	Malignant melanoma (Cell Line: UACC62)	[3]
Picoplatin + Mepacrine	DCTR5FC	Picoplatin	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Plicamycin + Mepacrine	DC5JZI5	Plicamycin	Adenocarcinoma (Cell Line: SW-620)	[3]
Plicamycin + Mepacrine	DCCJPXT	Plicamycin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Pralatrexate + Mepacrine	DC7XVTV	Pralatrexate	Clear cell renal cell carcinoma (Cell Line: A498)	[2]
Pralatrexate + Mepacrine	DCQBVC5	Pralatrexate	Papillary renal cell carcinoma (Cell Line: ACHN)	[2]
Pralatrexate + Mepacrine	DCDY0IP	Pralatrexate	Adenocarcinoma (Cell Line: HCT-15)	[3]
Pralatrexate + Mepacrine	DCOQJVY	Pralatrexate	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Raloxifene + Mepacrine	DC6GCO8	Raloxifene	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Raloxifene + Mepacrine	DCEU50R	Raloxifene	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Raloxifene + Mepacrine	DC6H61X	Raloxifene	Chronic myelogenous leukemia (Cell Line: K-562)	[2]
Raloxifene + Mepacrine	DCQAS7X	Raloxifene	Clear cell renal cell carcinoma (Cell Line: TK-10)	[2]
Raloxifene + Mepacrine	DCOB3WT	Raloxifene	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
Raloxifene + Mepacrine	DCW6XD1	Raloxifene	Glioma (Cell Line: SF-539)	[2]
Raloxifene + Mepacrine	DCRZ2XR	Raloxifene	Breast adenocarcinoma (Cell Line: MDA-MB-468)	[4]
Raloxifene + Mepacrine	DCBD5UM	Raloxifene	Invasive ductal carcinoma (Cell Line: BT-549)	[4]
Raloxifene + Mepacrine	DCH30QU	Raloxifene	Large cell lung carcinoma (Cell Line: NCI-H460)	[3]
Ruxolitinib + Mepacrine	DCAC9SV	Ruxolitinib	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Ruxolitinib + Mepacrine	DCCPZQ0	Ruxolitinib	Astrocytoma (Cell Line: SNB-19)	[2]
Ruxolitinib + Mepacrine	DCAD71Q	Ruxolitinib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
SCH 727965 + Mepacrine	DC3OZ62	SCH 727965	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Sorafenib + Mepacrine	DCEX5VI	Sorafenib	Adenocarcinoma (Cell Line: OVCAR3)	[2]
Sorafenib + Mepacrine	DCM7YVZ	Sorafenib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[2]
Sorafenib + Mepacrine	DCCPH48	Sorafenib	Papillary renal cell carcinoma (Cell Line: ACHN)	[2]
Taxol + Mepacrine	DCHL2IA	Taxol	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[2]
Taxol + Mepacrine	DCV75CP	Taxol	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Taxol + Mepacrine	DCNZRUM	Taxol	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Terameprocol + Mepacrine	DCSAROC	Terameprocol	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Terameprocol + Mepacrine	DCH0IAT	Terameprocol	Amelanotic melanoma (Cell Line: MDA-MB-435)	[3]
Terameprocol + Mepacrine	DCQM36H	Terameprocol	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Terameprocol + Mepacrine	DC0L9VF	Terameprocol	Malignant melanoma (Cell Line: UACC62)	[3]
Thioguanine + Mepacrine	DC8YCHE	Thioguanine	Adenocarcinoma (Cell Line: NCIH23)	[3]
Thioguanine + Mepacrine	DCW5UCM	Thioguanine	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Topotecan + Mepacrine	DCMOS7M	Topotecan	Carcinoma (Cell Line: MCF7)	[4]
Topotecan + Mepacrine	DC84DAM	Topotecan	Clear cell renal cell carcinoma (Cell Line: CAKI-1)	[3]
Topotecan + Mepacrine	DC72BE4	Topotecan	Cutaneous melanoma (Cell Line: SK-MEL-28)	[3]
Topotecan + Mepacrine	DCFSTFO	Topotecan	Glioma (Cell Line: SF-268)	[3]
Topotecan + Mepacrine	DCS8PZ0	Topotecan	Mixed endometrioid and clear cell carcinoma (Cell Line: IGROV1)	[3]
Topotecan + Mepacrine	DCK7TVC	Topotecan	Ovarian serous cystadenocarcinoma (Cell Line: SK-OV-3)	[3]
Topotecan + Mepacrine	DCRCP4V	Topotecan	Papillary renal cell carcinoma (Cell Line: ACHN)	[3]
Topotecan + Mepacrine	DCOLQPP	Topotecan	Pleural epithelioid mesothelioma (Cell Line: NCI-H226)	[3]
Topotecan + Mepacrine	DCP8HZJ	Topotecan	Renal cell carcinoma (Cell Line: UO-31)	[3]
Triapine + Mepacrine	DC6JOMK	Triapine	Invasive ductal carcinoma (Cell Line: T-47D)	[4]
Triapine + Mepacrine	DCDYUIB	Triapine	Adenocarcinoma (Cell Line: HCT116)	[3]
Triapine + Mepacrine	DC2NMH6	Triapine	Astrocytoma (Cell Line: U251)	[3]
Triapine + Mepacrine	DCX4DL9	Triapine	Plasma cell myeloma (Cell Line: RPMI-8226)	[3]
Trifluridine + Mepacrine	DCTJAN8	Trifluridine	Adult acute myeloid leukemia (Cell Line: HL-60(TB))	[2]
Trifluridine + Mepacrine	DCSRHJU	Trifluridine	Colon carcinoma (Cell Line: KM12)	[4]
Uracil mustard + Mepacrine	DCFSZLE	Uracil mustard	Lung adenocarcinoma (Cell Line: NCI-H522)	[3]
Valrubicin + Mepacrine	DCLLJ2V	Valrubicin	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-4)	[3]
Vandetanib + Mepacrine	DCK6VJB	Vandetanib	Plasma cell myeloma (Cell Line: RPMI-8226)	[3]
Vemurafenib + Mepacrine	DC9FGQA	Vemurafenib	Adenocarcinoma (Cell Line: HCT116)	[3]
Vemurafenib + Mepacrine	DC9WRW5	Vemurafenib	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[3]
Vemurafenib + Mepacrine	DCQ92SN	Vemurafenib	Chronic myelogenous leukemia (Cell Line: K-562)	[3]
Vemurafenib + Mepacrine	DC1O6RS	Vemurafenib	High grade ovarian serous adenocarcinoma (Cell Line: OVCAR-8)	[3]
Vemurafenib + Mepacrine	DCQRECU	Vemurafenib	Malignant melanoma (Cell Line: LOX IMVI)	[3]
Vincristine + Mepacrine	DCB1Y9I	Vincristine	Adult T acute lymphoblastic leukemia (Cell Line: MOLT-4)	[2]
Vincristine + Mepacrine	DC0DQAH	Vincristine	Anaplastic large cell lymphoma (Cell Line: SR)	[2]
Vincristine + Mepacrine	DCDJAJE	Vincristine	Childhood T acute lymphoblastic leukemia (Cell Line: CCRF-CEM)	[2]
Vincristine + Mepacrine	DCGM7D1	Vincristine	Lung adenocarcinoma (Cell Line: HOP-62)	[2]
Vincristine + Mepacrine	DCGDJPX	Vincristine	Malignant melanoma (Cell Line: UACC62)	[2]
Vinflunine + Mepacrine	DCGEI7Y	Vinflunine	Adenocarcinoma (Cell Line: SW-620)	[3]
Vinflunine + Mepacrine	DCY1VX7	Vinflunine	Adenocarcinoma (Cell Line: HCT116)	[3]
Vinflunine + Mepacrine	DC8RYEJ	Vinflunine	High grade ovarian serous adenocarcinoma (Cell Line: NCI\\/ADR-RES)	[3]
Vismodegib + Mepacrine	DC54IHC	Vismodegib	Clear cell renal cell carcinoma (Cell Line: 786-0)	[3]
------------------------------------------------------------------------------------


⏷ Show the Full List of 271 DrugCom(s)

References

1	Involvement of protein kinase C activation in L-leucine-induced stimulation of protein synthesis in l6 myotubes. Cytotechnology. 2003 Nov;43(1-3):97-103.
2	Recurrent recessive mutation in deoxyguanosine kinase causes idiopathic noncirrhotic portal hypertension.Hepatology. 2016 Jun;63(6):1977-86. doi: 10.1002/hep.28499. Epub 2016 Mar 31.
3	Loss of function mutations in VARS encoding cytoplasmic valyl-tRNA synthetase cause microcephaly, seizures, and progressive cerebral atrophy.Hum Genet. 2018 Apr;137(4):293-303. doi: 10.1007/s00439-018-1882-3. Epub 2018 Apr 24.
4	Biologically active neutrophil chemokine pattern in tonsillitis.Clin Exp Immunol. 2004 Mar;135(3):511-8. doi: 10.1111/j.1365-2249.2003.02390.x.